STR1VE Trial of Onasemnogene Abeparvovec for SMA

(3:35)

Data from STR1VE EU and STR1VE US Confirm Efficacy of Gene Therapy

(3:12)

Advances in Gene Therapy for Neuromuscular Diseases

(4:10)

Onasemnogene Clinical Trial Data

(3:33)

START trial long-term follow-up of onasemnogene abeparvovec in SMA

(2:14)

TWiV 1190: Clinical update with Dr. Daniel Griffin

(47:1econd)

How is a clinical trial developed? And what is the clinical trial process?

(3:1econd)

Early TAVR Trial Whiteboard

(4:38)

Stem Cell Harvesting and Banking Clinical Trial at CHOP

(52:49)

Bad News From a Gene Therapy Trial

(17:9)

Video #127 - WHAT IS AVXS-101 And Who Is AveXis?

(11:15)

A day in the life of a clinical trial patient

(2:44)

Participating in a Clinical Trial

(2:13)

Controversial Clinical Trial Requires Patients Pay $1M | S1 - E02

(6:4)

An Overview of Clinical Trials

(9:13)

MILESTONE trial results: MRD response-adapted deferral of autoSCT in newly diagnosed myeloma

(2:27)

Phase I trial of IMA401, a MAGEA4/8-directed T cell receptor bispecific in solid tumors

(1:47)

Feasibility trial of intensive vs. standard BP control after endovascular treatment

(2:7)

Welcome to the REACH trial group 1 - information for REACH trial participants

(13:32)